Riskpilot← Back to searchSign inGet full accessProtein Frontiers ApS
APSActiveCVR 43132709C L Ibsens Vej 7, st.Research and experimental development on natural sciences and engineering · NACE 7210Est. 20225 employeesproteinfrontiers.dk
Revenue 2024
DKK 768K
+26% vs 2023
EBITDA margin
100.0%
+26% vs 2023
Equity ratio
97.0%
Financial strength
Net profit 2024
DKK 601K
+10% vs 2023
| Revenue | DKK 768K | +26% |
| EBITDA | DKK 768K | +26% |
| Net profit | DKK 601K | +10% |
| Total assets | DKK 1,1M | -16% |
| Equity | DKK 1,1M | +129% |
| Employees | 5 | — |
Legal name
Protein Frontiers ApS
CVR number
43132709
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
10. marts 2022
Share capital
DKK 125.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion sammen med bestyrelsesformanden.
Company purpose
Selskabets formål er at drive virksomhed med forskning, udvikling og kommercialisering af aktiviteter til produktion af rekombinant cellulære proteiner til fødevarer på medier af sidestrømme. Herunder at udvikle teknikker til industriel opskalering af disse proteiner og afledte produkter heraf samt indgåelse af global eksklusiv aftaler til udnyttelse af patenter.
Address
C L Ibsens Vej 7, st.
Phone
+4530668660
Email
soenksen@proteinfrontiers.dk
Website
proteinfrontiers.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | -180 | 610 | 768 |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | -180 | 610 | 768 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -180 | 610 | 768 |
| Net financials | -0 | -4 | -2 |
| Profit before tax | -180 | 606 | 766 |
| Tax | -0 | 60 | 165 |
| Net profit | -180 | 546 | 601 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 226 | 1.311 | 1.099 |
| Equity | -80 | 465 | 1.067 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 307 | 846 | 33 |
| Total debt | 307 | 846 | 33 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20222024
Equity ratio
97.0%
This company
38.2%
Market median
+154% vs market
20222024
Return on equity
56.4%
This company
18.4%
Market median
+207% vs market
20222024
Net profit margin
78.3%
This company
8.1%
Market median
+867% vs market
20222024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20222024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-03-10 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HS Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Solheim22 Holding ApS | Company | 20.0% | 20.0% | 2022 |
Viridis Futurum ApS | Company | 20.0% | 20.0% | 2025 |
MPLU Biorefining Aps | Company | 20.0% | 20.0% | 2022 |
NKS Investment ApS | Company | 20.0% | 20.0% | 2022 |
H Sønksen Holding ApS | Company | 20.0% | 20.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MPLU Biorefining Aps
Protein Frontiers ApS Board members of Protein Frontiers ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Sønksen | Management | 0 companies |
| Peter Lübeck | Deputy Chairman | 0 companies |
| Hans Peder Morten Laursen Meldgaard | Board of Directors | 0 companies |
| Lasse Solheim Hansen | Board of Directors | 0 companies |
| Mette Lübeck | Board of Directors | 0 companies |
| Niels Kristian Sørensen | Chairman | 0 companies |